Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
Thomas McFall(Salk Institute for Biological Studies), Edward C. Stites(Yale Cancer Center)
Cited by 16
Related Papers
Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation
|npj Systems Biology and Applications|2024|3